Market revenue in 2021 | USD 4.1 billion |
Market revenue in 2030 | USD 6.7 billion |
Growth rate | 5.7% (CAGR from 2021 to 2030) |
Largest segment | Anti-hypertensive |
Fastest growing segment | Hormones |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD billion |
Market segmentation | Alkylating Agents, Antimetabolites, Hormones, Anti-hypertensive, Lipid Lowering drugs, Anti-depressants, Anti-psychotics, Anti-epileptics |
Key market players worldwide | Teva Pharmaceutical Industries Ltd, Lupin, Sanofi SA, Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, GlaxoSmithKline, Pfizer Inc, Apotex Inc., Viatris Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to branded generics market will help companies and investors design strategic landscapes.
Anti-hypertensive was the largest segment with a revenue share of 14.63% in 2021. Horizon Databook has segmented the Saudi Arabia branded generics market based on alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics covering the revenue growth of each sub-segment from 2018 to 2030.
The Saudi Arabian market is projected to witness moderate growth over the forecast period owing to factors such as increase in government initiatives coupled with availability of products for affordable treatment.
The local pharmaceutical companies manufacture around one-quarter of the medicines in the Saudi Arabian market, which is expected to increase by 40% in the long term through initiatives and funding.
According to an NCBI report, most primary care physicians support generics more than private and hospital physicians. According to a report in the country, local sales force, such as medical representatives, plays a crucial role in promoting the drugs.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia branded generics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia branded generics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account